|
|
| | Erlotinib Impurity 20 Basic information |
| Product Name: | Erlotinib Impurity 20 | | Synonyms: | 2-amino-4,5-bis(2-methoxyethoxy)benzamide;2-amino-4,5-bis(3-methoxypropyl)-benzamide;Erlotinib impurity 17/2-amino-4,5-bis(2-methoxyethoxy)benzamide;Erlotinib Impurity R;6,7-bis(2-methoxyethoxy)quinazolin-4-amine;Erlotinib Hydrochloride iMpurity 12;Erlotinib Hydrochloride iMpurity 17;Erlotinib-13 | | CAS: | 236750-62-2 | | MF: | C13H20N2O5 | | MW: | 284.31 | | EINECS: | | | Product Categories: | | | Mol File: | 236750-62-2.mol |  |
| | Erlotinib Impurity 20 Chemical Properties |
| Boiling point | 408.3±45.0 °C(Predicted) | | density | 1.198±0.06 g/cm3(Predicted) | | pka | 15.77±0.50(Predicted) |
| | Erlotinib Impurity 20 Usage And Synthesis |
| Uses | 2-Amino-4,5-bis(2-methoxyethoxy)benzamide is an impurity of Erlotinib (E625008), a EGFR-targeted drug in the treatment of non-small cell lung cancer. EGFR small tyrosine kinase inhibitor that shows most substantial effect on tumor growth inhibition and animal survival. |
| | Erlotinib Impurity 20 Preparation Products And Raw materials |
|